comparemela.com

Steven Cohen (Trades, Portfolio), through Point72 Asset Management, has recently made a notable adjustment in the firm's investment portfolio by reducing its stake in Crinetics Pharmaceuticals Inc (NASDAQ:CRNX). This trade has altered the firm's portfolio by a -0.09% impact, with CRNX now representing 0.36% of the total portfolio and 5.10% of the firm's holdings in the traded stock.

Related Keywords

United States , ,Crinetics Pharmaceuticals Inc ,Fisher Asset Management ,Pharmaceuticals Inc ,Steven Cohen ,Financial Strength ,Profitability Rank ,Growth Rank ,Momentum Rank ,Asset Management ,Crinetics Pharmaceuticals ,Point72 Asset Management ,Grades ,Investment Portfolio ,Meta Platforms Inc ,Portfolio ,Crnx ,Healthcare Sectors ,Urrent Stock Price ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.